看到這系列新聞，我第一反應是覺得蔡政府又在豪洨+牽拖
抱著懷疑的態度去搜尋英文泰國新聞，結果還真的讓我找到這個
底下有機翻，這看起來是泰國當地的媒體
https://www.thaienquirer.com/28401/thailand-delays-astrazeneca-exports-to-othe
r-countries-as-local-inoculation-drive-begins/
https://shorturl.at/dpquA
By
Cod Satrusayang
June 10, 2021
Thailand is delaying locally-produced AstraZeneca vaccines to neighboring
countries while it focuses on inoculating its own citizens, a source told
Thai Enquirer on Thursday.
There have been problems scaling up production at Siam Bioscience, AZ’s
local partner and its sole regional producer, as has previously been reported
in Thai Enquirer. (Read more here)
Malaysia, Taiwan, and the Philippines have been informed by the Thai side
that orders for the AZ vaccine have been delayed by at least a month,
according to a report by Reuters.
The delay has been confirmed by multiple government officials across the
region. A source inside Thailand’s Ministry of Public Health told Thai
Enquirer that part of the reason for the delay is because the Thai government
has decided to focus first on inoculating its own citizens.
“I think the government has been criticized from all sides due to its
decision to heavily rely on SBS vaccines and it is especially sensitive right
now,” the source told Thai Enquirer by phone.
“So they are halting or delaying exports of the vaccine to focus on the
inoculation drive to gain back some credit.”
Thailand’s mass inoculation plans began this week on Monday and as of
Thursday morning has seen over 3 million people administered with the first
dose of the vaccine.
“I don’t know if this is going to create conflict with AstraZeneca but I do
know this is a positive decision for the Thai people,” the source added. “
The government is putting its people first even if it is to save face.”
Calls to AstraZeneca Thailand were not returned.
六月10日，2021
一位消息人士周四告訴泰國詢問報，泰國正在推遲向鄰國提供本地生產的阿斯利康疫苗，
同時專注於為本國公民接種疫苗。
正如泰國詢問者先前報導的那樣，在擴大生產規模方面，AZ 的當地合作夥伴及其唯一的
區域生產商 Siam Bioscience 出現了問題。 （在這裡閱讀更多）
據路透社報導，泰國方面已通知馬來西亞、台灣和菲律賓，AZ疫苗的訂單至少推遲了一個
月。
該地區的多位政府官員證實了這一延誤。泰國公共衛生部的一位消息人士告訴《泰國詢問
報》，延遲的部分原因是泰國政府決定首先專注於為本國公民接種疫苗。
“我認為政府因其決定嚴重依賴 SBS 疫苗而受到了各方的批評，現在特別敏感，”消息
人士通過電話告訴泰國詢問者。
“因此，他們正在停止或推遲疫苗的出口，以專注於疫苗接種工作，以贏回一些信用。”
泰國的大規模接種計劃於本週一開始，截至週四上午，已有超過 300 萬人接種了第一劑
疫苗。
“我不知道這是否會與阿斯利康產生衝突，但我知道這對泰國人民來說是一個積極的決定
，”消息人士補充道。 “即使是為了挽回面子，政府也將人民放在首位。”
打給泰國阿斯利康的電話沒有得到回复。